(Q44851401)

English

A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients

scientific article published in April 2004

Statements

A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients (English)
Scott McCallister
Hernan Valdez
Kevin Curry
Thomas MacGregor
Marie Borin
William Freimuth
Yenyung Wang
Douglas L Mayers
1 April 2004
376-382

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit